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5,16-dihydrotanshinone I (DHTS) is extracted from Salvia miltiorrhiza Bunge (tanshen root) and was found to be the most
eﬀective compound of tanshen extracts against breast cancer cells in our previous studies. However, whether DHTS can induce
apoptosis through an endoplasmic reticular (ER) stress pathway was examined herein. In this study, we found that DHTS
signiﬁcantly inhibited the proliferation of human prostate DU145 carcinoma cells and induced apoptosis. DHTS was able to
induce ER stress as evidenced by the upregulation of glucose regulation protein 78 (GRP78/Bip) and CAAT/enhancer binding
protein homologous protein/growth arrest- and DNA damage-inducible gene 153 (CHOP/GADD153), as well as increases in
phosphorylated eukaryotic initiation factor 2α (eIF2α), c-jun N-terminal kinase (JNK), and X-box-binding protein 1 (XBP1)
mRNAsplicingforms.DHTS treatment alsocaused signiﬁcantaccumulationofpolyubiquitinated proteins andhypoxia-inducible
factor (HIF)-1α, indicating that DHTS might be a proteasome inhibitor that is known to induce ER stress or enhance apoptosis
causedbythe classicERstress-dependent mechanism.Moreover, DHTS-induced apoptosiswasreversed bysalubrinal,anERstress
inhibitor. Results suggest that DHTS can induce apoptosis of prostate carcinoma cells via induction of ER stress and/or inhibition
of proteasome activity, and may have therapeutic potential for prostate cancer patients.
1.Introduction
The endoplasmic reticulum (ER) has several critical func-
tions in cells including protein synthesis, folding, and
posttranslational modiﬁcation, as well as the regulation
of intracellular calcium homeostasis [1]. Any factors that
disrupt the ER structure and function will ultimately
cause defects in protein synthesis, folding, modiﬁcation,
and accumulation in the ER. These abnormal proteins are
unfolded or misfolded proteins, which can all challenge
the function of the ER-Golgi network and result in ER
stress [2]. Cases of intense or persistent ER stress can
trigger apoptosis [3]. Besides abnormal proteins, ceramide
generation induced by Ca2+-independent phospholipase A2
(iPLA2β)alsoparticipatesinERstress-induced cellapoptosis
[4].Theunfoldedproteinresponse(UPR)isacytoprotective,
signaling pathways in response to ER stress in cells [5]. In
mammals, three ER transmembrane proteins are activated
in the UPR, including inositol requiring 1 (IRE1), protein
endoplasmic-reticular-resident kinase (PERK), and ATF6,2 Evidence-Based Complementary and Alternative Medicine
a transcription factor [6]. The PERK enhances translation of
thetranscription factor, ATF4,evenasitrepresses translation
of many other proteins through eukaryotic initiation factor
2α (eIF2α) in a phosphorylation-dependent manner [7].
Upon ER stress, active IRE1 results in altered splicing of
X-box-binding protein 1 (XBP1) messenger (m)RNA for
encoding the functional XBP1 transcription factor, and
may lead to apoptosis by stimulating phosphorylation of
c-Jun N-terminal kinase (JNK) and the p38 mitogen-
activated protein kinase (MAPK) [8]. ATF6 is activated
by S1P and S2P proteases, leading directly to the tran-
scription of the CAAT/enhancer binding protein homol-
ogous protein/growth arrest- and DNA damage-inducible
gene 153 (CHOP/GADD153) by interaction with a speciﬁc
nucleotide-binding sequence [9]. These pathways eventually
activate transcription of ER chaperones, such as glucose
regulation protein 78 (GRP78/Bip) and proteins involved in
ER-associated degradation (ERAD), which serve to restore
ER homeostasis and protect cells by eliminating ER stress
[10]. The ERAD system is responsible for transferring mis-
foldedproteinsfrom the ERlumen tothe cytosol,where they
are ubiquitinated and degraded by proteasomes. Proteasome
inhibitors, such as bortezomib, prevent misfolded protein
degradation, block the ERAD system, and subsequently
resultin inductionofERstress- andER-dependentapoptosis
[11].
Salvia miltiorrhiza Bunge(tan shen root)is awell-known
plant used in traditional Chinese medicine to treat various
entities, such as cardiovascular disease, angina pectoris,
hyperlipidemia, and acute ischemic stroke [12, 13]. Tan
shen extracts contain several constituents including water-
soluble phenolic acids and lipophilic tanshinones [14].
Recently, other studies and our own found that extracts of
tan shen exhibit signiﬁcant antitumor activity by diﬀerent
mechanisms in various types of tumor cells. We previously
showed that DHTS markedly inhibited the proliferation of
breast cancer cells through induction of G1-phase arrest
and increased loss of the mitochondrial membrane potential
and cytochrome c release [15]. Moreover, the inhibitory
activity was ranked as follows: DHTS > tanshinone I >
cryptotanshinone I. Tanshinone I was also shown to induce
cancer cell apoptosis in human myeloid leukemia cells
[16] and human nonsmall cell lung cancer [17]w h e r e a s
tanshinone IIA induced apoptosis in human HeLa [18]
and rat glioma cells [19]. Although various mechanisms
were proposed to explain the antitumor eﬀects of the
diﬀerent tan shen constituents, such as inactivation of the
PI3K/Akt/survivin signaling pathways [16], reductions of
interleukin (IL)-8, Ras-mitogen-activated protein kinase,
Rac1 [17], interference with microtubule assembly [18], and
inhibition of constitutive STAT3 activation [19], this issue
has not been convincingly clariﬁed.
In the present study, we show that DHTS is able to
potentlyinduceER stress in prostate carcinoma cells, as indi-
catedbyelevatedlevelsofGRP78/BipandCHOP/GADD153,
leading to apoptosis. Moreover, DHTS caused the accumu-
lation of polyubiquitinated proteins and HIF-1α, indicating
that DHTS might be a proteasome inhibitor which produces
ER stress or enhanced apoptosis caused by the classic ER
stress-dependent mechanism.
2.Materialsand Methods
2.1. Materials. DHTS was purchased from Xi’an Honson
Biotechnology (Xi’an, China). The purity was about 95%
according to a high-performance liquid chromatographic
(HPLC) analysis.
2.2. Cell Culture. The human prostate carcinoma cell line,
DU145(BCRC60348),wasobtainedfromtheFoodIndustry
Research and Development Institute (Hsinchu, Taiwan)
and cultured in 90% minimum essential medium (MEM)
containing 10% heat-inactivated fetal bovine serum (FBS;
Invitrogen Taiwan, Taipei, Taiwan). Cells were plated in 6-
cm dishes at 5 ×106 cells per dish except the MTT assay, and
allowed to grow for 24h.
2.3.3-(4,5-Dimethyl-2-Thiazolyl)-2,5-Diphenyl-2H-Tetra-zol-
ium Bromide (MTT) Assay. Cells (1 × 104 cells/mL) were
cultured in a 24-well plate for 24h and then treated with
DHTS for various time periods. The cell viability was
determined by an MTT assay as described previously [15].
2.4. Western Blot Analysis. Total cellular proteins (50∼75μg)
were resolved by 10% or 12% sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred onto a polyvinylidene diﬂuoride (PVDF) membrane
(Millipore, Bedford, MA) as described previously [20]. The
membrane was then incubated with the following pri-
mary antibodies: anti-PARP, anti-GRP78/Bip, anti-CHOP/
GADD153,antiubiquitin,anti-HIF-1α, antiphosphor-eIF2α,
antiphosphor-JNK, antiphosphor-PERK, anticleaved caspase
3, anticleaved caspase 8, anticleaved caspase 9 (Cell Sig-
naling Technology, Danvers, MA), and anti-Bcl-2 (Santa
Cruz Biotechnology, Santa Cruz, CA). he membranes were
subsequently incubated with anantimouse or antirabbit
immunoglobulin G (IgG) secondary antibody conjugated
to horseradish peroxidase (HRP; Santa Cruz Biotechnology)
and visualized using enhanced hemiluminescence (ECL) kits
(Santa Cruz Biotechnology).
2.5. Reverse-Transcription Polymerase Chain Reaction (RT-
PCR). Total RNA was isolated fromcultured cells and com-
plementary (c) DNA was prepared as previously described
[21]. XBP1 cDNA was ampliﬁed by incubating 500ng
equivalents of total cDNA in 100mM Tris-HCl buﬀer
(pH 8.3) containing 500mM KCl, 15mM MgCl2,0 . 1 %
gelatin, 200μM of each deoxyribonucleotide triphosphate
(dNTP), and 50units/mL Super Taq DNA polymerase
with the following oligonucleotide primers: 5 -AACAGA-
GTAGCAGCTCAGACTGC-3  and 5 -TCCTTCTGGGTA-
GACCTCTGGGAG-3 . The cDNA of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was also ampliﬁed as
a control in the same method using the following primers:Evidence-Based Complementary and Alternative Medicine 3
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Figure 1:Eﬀects ofDHTS ontheviabilityandcell morphologyofhumanprostatecarcinomacells. (a)DU145cells were treated withvarious
concentrations of DHTS for 8, 12, or 24h, and cell viability was determined by an MTT assay. Values were obtained in three independent
experiments performed in triplicate and are represented as the mean ± S.E. (b) DU145 cells were treated with various concentrations of
DHTS for 24h and photographed. (c) DU145 cells were treated with 1.5μg/mL of DHTS for various time points and photographed.
5 -TGAAGGTCGGTGTGAACGGATTTGGC-3  and 5 -
CATGTAGGCCATGAGGTCCACCAC-3 . Thermal cycle
conditionswereasfollows:1cycleat94◦Cfor5min,followed
by 30 cycles at 94◦C for 30s, 58◦Cf o r4 5 s ,a n d6 8 ◦Cf o r
1min, with a ﬁnal cycle at 72◦C for 10min. PCR products
were analyzed on 1% agarose gels.
2.6. Flow Cytometric Analysis of Apoptotic Cell Death. Apop-
totic cell death was analyzed by ﬂow cytometry using the
Annexin V-conjugated Alexa Fluor 488 Apoptosis Detection
Kit according the manufacturer’s instructions (Molecular
Probes, Eugene, OR) [15].
2.7.Statistical Analysis. Dataarepresentedas themean ±the
standard error (S.E.) for the indicated number of indepen-
dently performed experiments. Signiﬁcantly diﬀerent with
P<. 05 using one-way Student’s t-test.
3.Results
3.1. Eﬀects of DHTS on Apoptosis of Prostate Carcinoma Cells.
In human prostate DU145 carcinoma cells, DHTS signif-
icantly induced cell death in dose- and time-dependent
manners, and showed a 64.92% and 91.18% reduction of
cell viability with 0.1μg/mL and 1.5μg/mL of DHTS,respec-
tively, at 24h of treatment (Figure 1(a)). Using microscopic4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀects of DHTS on apoptosis in human prostate carcinoma cells. DU145 cells were treated with various concentrations of
DHTS for 24h, and apoptotic cells were determined by FACS using an Annexin V-Alexa Fluor488 Apoptosis Assay Kit. The experiment
was performed three times, and representative data are shown.
observations, cell shrinkage and rounding were found in
DHTS-treated cells in dose- and time-dependent manners
(Figures 1(b) and 1(c)). Cell death was also character-
ized using ﬂow cytometry with propidium iodide (PI)
and Annexin V-Alexa Fluor 488 staining. The lower right
quadrant of the FACS histogram represents early apoptotic
cells, which were stained with the green ﬂuorescent Alexa488
dye, and the upper right quadrant of the FACS histogram
represents late apoptotic cells, which were stained with both
the red-green ﬂuorescence PI and Alexa488 dyes. As shown
in Figure 2, the late apoptotic cell population increased from
11.05% to 35.95% in cells treated with 1.5μg/mL DHTS.
We next determined the cleavage of PARP and activation of
caspases in DHTS-treated cells. After treatment with DHTS
for 24h, the cleavage of PARP and cleavage forms (active
caspases) of caspases 3 and 9 were found in DHTS-treated
cells in a dose-dependent manner (Figure 3). However,
neither Bcl-2 expression nor the cleaved form of caspase 8
changed in DHTS-treated cells. These results suggest that
DHTS induced cell death through an apoptotic pathway in
prostate carcinoma cells.
3.2. Eﬀects of DHTS on the Induction of ER Stress. To
examine whether DHTS causes ER stress in prostate DU145
DHTS
Control 0.1 0.5 1 1.5 (μg/mL)
PARP
Cleaved PARP
Cleaved caspase 9
Cleaved caspase 8
Cleaved caspase 3
Bcl-2
α-tubulin
Figure 3: Eﬀects of DHTS on the cleavage of caspases and PARP
in human prostate carcinoma cells. DU145 cells were treated with
various concentrations of DHTS for 24h, and total cellular protein
was subjected to Western blotting to detect cleavage of caspases-9,
-3, and -8, PARP, and Bcl-2.Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: Eﬀects of DHTS on the induction of ER stress-related protein expression and XBP1 mRNA splicing in humanprostate carcinoma
cells. (a) DU145 cells were treated with 1.5μg/mL DHTS for the indicated time periods, and (b) DU145 cells were treated with various
concentrationsofDHTSfor12h(CHOP,p-eIF2α,p-JNK,andp-PERK)or24h(GRP78/Bip).Totalcellularproteinwassubjected toWestern
blotting to detect the expressions of GRP78/Bip, CHOP/GADD153, phosphor-eIF2α, phosphor-JNK, and phosphor-PERK. (c) DU145 cells
were treated with 1.5μg/mL DHTS for the indicated time periods, and total RNA was collected for detecting XBP1 mRNA expression by
RT-PCR.
carcinoma cells, several ER-responsive proteins and ER-
speciﬁc signals were detected. We ﬁrst measured the expres-
sions of GRP78/Bip, which plays a role as gatekeeper in acti-
vating ER stress, and CHOP/GADD153, a transcription fac-
tor increased by ER stress. The Western blot analysis showed
that the expressions of GRP78/Bip and CHOP/GADD153
signiﬁcantly increased after DHTS treatment in dose- and
time-dependent manners (Figure 4). We next detected the
phosphorylation of ER-speciﬁc signals, including PERK,
eIF2α,a n dJ NK,w h i c ha r ek n o wnt ob ea c t i v a t e di nr e s p o n s e
toaccumulatedunfoldedproteinsintheERlumen.Asshown
in Figure 4, DHTS indeed induced the phosphorylation of
PERK, its substrate, eIF2α, and JNK in dose- and time-
dependent manners. The results suggested that DHTS is able
to induce ER stress in prostate DU145 carcinoma cells.
3.3. Eﬀects of DHTS on Inhibiting Proteasome Activity. To
examine whether DHTS can inhibit proteasome activity,
cause ER stress, block UPR, and subsequently trigger apop-
tosis, lysates of cells treated with DHTS were subjected to
a Western blot analysis with an antibody against ubiquitin.
As shown in Figure 5, polyubiquitinated proteins of various
sizes were observed in DHTS-treated cells in a time-
dependent manner. The rapidly degradable protein, HIF-1α,
was also found to accumulate in DHTS-treated cells. These
results suggest that proteasome activity is indeed inhibited
by DHTS treatment.
3.4. Eﬀects of an ER Stress Inhibitor on Reversing DHTS-
Induced Apoptosis. It was suggested that prolonged ER stress
can cause cells to undergo apoptosis. To test whether DHTS-
induced apoptosis is mediated by ER stress, salubrinal, an
inhibitor of eIF2α, was used to block DHTS-induced ER
stress. Induction of apoptosis by DHTS was signiﬁcantly
reduced by salubrinal (Figure 6), indicating that DHTS-
induced apoptosis is partially mediated by ER stress.
4.Discussion
T a ns h e ni sw i d e l yu s e di nC h i nese traditional medicine,
and it contains many bioactive ingredients including
water-soluble phenolic acids and lipophilic tanshinones.6 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Eﬀects of the eIF2α inhibitor, salubrinal, on reversing apoptosis induced by DHTS in human prostate carcinoma cells. DU145
cells were pretreated with various concentrations of salubrinal for 1h followed by an additional treatment with 1 or 1.5μg/mL of DHTS for
24h. Cell viability was determined by an MTT assay, and data are presented as the mean ± S.E. of three independent experiments. ∗P<. 05,
compared to individual DHTS-treated cells.Evidence-Based Complementary and Alternative Medicine 7
Other previous studies and our own showed that DHTS, one
of the most eﬀective of the tanshinones, was able to induce
apoptosis in a number of human cancer cell lines [15–19],
but the exact molecular mechanisms accounting for DHTS-
induced apoptosis are not yet fully understood. In this study,
we evaluated the activity of DHTS in inhibiting the growth
of human prostate carcinoma cells. We found that DHTS
induced apoptosis through inhibiting proteasome activity,
increasing ER stress, and subsequently inducing apoptosis
(Figure 7). The present study provides crucial evidence to
support the involvement of ER stress in the induction of
apoptosis by DHTS in human prostate carcinoma cells.
Abundant evidence demonstrated that androgens and
the androgen receptor are associated with the development
and progression of prostate pathogenesis [22]. In addition to
androgen-independent DU145 cells, androgen-independent
PC3 cells and androgen-dependent LNCaP prostate cancer
cells were used to analyze the apoptotic activity of DHTS.
Our results indicated that DHTS signiﬁcantly inhibited
both the proliferation of androgen-dependent LNCaP and
androgen-independent PC3 and DU145 cells in the same
manner (data not shown), suggesting that the antiprolifera-
tive eﬀects of DHTS are not irrelevant to the androgen signal
pathway.
Reactive oxygen species (ROS) are known to inhibit
ER calcium pumps and ultimately result in depletion of
ER calcium stores. The shortage of ER calcium causes a
deterioration in the proper folding of proteins in the lumen
of the ER and causes ER stress [23]. In this study, we
found that DHTS signiﬁcantly induced ER stress, such as
upregulation of GRP78/Bip and CHOP/GADD153 protein
expressions and PERK, eIF2α, and JNK phosphorylation
(Figure 4). Other studies demonstrated that tanshinones,
including DHTS, are able to induce ROS generation, and
that ROS-mediated p38 MAPK activation plays a vital role
in DHTS-induced apoptosis in HepG2 cells [24]. DHTS-
generatedROSmightcontributetotheinductionofERstress
in prostate carcinoma cells, but this hypothesis needs to be
proven in the future.
ER stress occurs, cells can activate cytoprotective signal-
ing pathways, termed the unfolded protein response (UPR),
to inhibit the bulk translation via phosphorylated-eIF-2α
andincreasedegradationofmisfoldedoraggregatedproteins
via proteasomes [25, 26]. Inhibition of proteasome activity
was shown to enhance the antitumor activity of cisplatin
and other agents that induce cell death via the classic ER
stress-dependent mechanism [27]. Our results showed that
DHTS might be a proteasome inhibitor due to observations
of the accumulationof polyubiquitinatedproteins in DHTS-
treated cells (Figure 5). It is therefore possible that DHTS-
induced cell apoptosis might be enhanced by its inhibition
of proteasome activity, and both ER stress induction and
proteasome inhibition are important in DHTS-induced
apoptosis in prostate carcinoma cells.
In responses to ER stress, cells transcriptionally induced
GRP78/Bip, a chaperone which assists the folding of nascent
unfolded proteins and relieves ER stress [28]. However,
if ER stress continues, cells express CHOP/GADD153,
a transcription factor that regulates genes involved in
Survival
ERAD
Proteasome ?
ER stress
DHTS
p-JNK XBP-1 splicing p-PERK
Apoptosis Chop p-elF2α
Figure 7: The possible mechanisms of DHTS-induced ER stress
and apoptosis in human prostate carcinoma cells. First, DHTS
may induce ER stress through inhibiting proteasome activity or
unknown pathways. Second, ER stress induces UPR as evidenced
by the upregulation of GRP78/Bip, CHOP/GADD153, and XBP1
mRNA splicing forms as well as increase of the phosphorylation
of eIF2α and JNK. In addition, ER stress may induce ERAD,
which degrades misfoldedproteins mediated by proteosome. Third,
prolonged ER stress causes cells to undergo apoptosis through
activation of CHOP and JNK, and further promoting apoptosis
through inhibition of ERAD by DHTS. Solid lines are used to
indicate activating pathways, and dashed lines are used to indicate
inhibiting pathways.
apoptosis. Previous studies identiﬁed that CHOP/GADD153
might promote ER stress-induced cell apoptosis by down-
regulating Bcl-2 expression [29, 30]. In addition, DU145
prostate carcinoma cells were demonstrated to be resis-
tant to Fas-induced apoptosis through upregulating Bcl-
2 expression [31]. Cryptotanshinone, a major tanshinone,
was found to sensitize DU145 prostate carcinoma cells to
Fas-mediated apoptosis through suppressing Bcl-2 expres-
sion and augmenting Fas [31]. In the present study, we
demonstrated that CHOP/GADD153wasinduced inDHTS-
treated cells (Figure 4), and inhibition of CHOP/GADD153
upstream eIF-2α partially reversed DHTS-inducedapoptosis
(Figure 6). However, the expression of Bcl-2 did not change
in DHTS-treated cells, suggesting that DHTS-induced apop-
tosisand CHOP/GADD153-mediatedapoptosismightoccur
in a Bcl-2-independent manner, and the underlying mecha-
nisms of the apoptotic eﬀects of DHTS diﬀer from those of
cryptotanshinone.
In conclusion, our study demonstrated that DHTS
induces the apoptosis of human prostate carcinoma cells.
The inhibitory eﬀects of DHTS were independent of
functional Bcl-2 and had no relationship with androgen
responses. In this study, we ﬁrst demonstrated that both
ER stress and proteasome inhibition contribute to DHTS-
induced apoptosis in DU145 prostate carcinoma cells. How-
ever, the detailed mechanisms through which DHTS causes
ER stress and inhibits proteasome activity remain to be
investigated.8 Evidence-Based Complementary and Alternative Medicine
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